Optimizing the presentation of bleeding and thrombosis data: Responding to censored data using Kaplan-Meier curves.
作者信息
Bouck E G, Zunica E R, Nieman M T
机构信息
Department of Pharmacology, Case Western Reserve University, Cleveland, OH, USA.
出版信息
Thromb Res. 2017 Oct;158:154-156. doi: 10.1016/j.thromres.2017.09.011. Epub 2017 Sep 12.
Abstract
摘要
相似文献
1
Optimizing the presentation of bleeding and thrombosis data: Responding to censored data using Kaplan-Meier curves.
Thromb Res. 2017 Oct;158:154-156. doi: 10.1016/j.thromres.2017.09.011. Epub 2017 Sep 12.
2
Antiplatelet Therapy and Adverse Hematologic Events During Heart Mate II Support.
Circ Heart Fail. 2016 Jan;9(1):e002296. doi: 10.1161/CIRCHEARTFAILURE.115.002296.
3
Analysis of noncatheter-associated upper extremity deep venous thrombosis from the RIETE registry.
J Vasc Surg Venous Lymphat Disord. 2017 Jan;5(1):18-24.e1. doi: 10.1016/j.jvsv.2016.08.002. Epub 2016 Oct 27.
4
Understanding Kaplan-Meier and survival statistics.
Int J Prosthodont. 2013 May-Jun;26(3):218-26. doi: 10.11607/ijp.3406.
5
The underappreciated risk of thrombosis and bleeding in patients with myelofibrosis: a review.
Ann Hematol. 2017 Oct;96(10):1595-1604. doi: 10.1007/s00277-017-3099-2. Epub 2017 Aug 14.
6
Antithrombotic strategy after bioprosthetic aortic valve replacement in patients in sinus rhythm: evaluation of guideline implementation.
Eur J Cardiothorac Surg. 2016 Apr;49(4):1157-63. doi: 10.1093/ejcts/ezv254. Epub 2015 Aug 1.
7
Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis.
Europace. 2011 May;13(5):723-46. doi: 10.1093/europace/eur126.
8
Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial.
Lancet. 2009 Oct 3;374(9696):1149-59. doi: 10.1016/S0140-6736(09)61484-7. Epub 2009 Aug 28.
9
Splenomegaly and thrombosis risk in essential thrombocythemia: the Mayo Clinic experience.
Am J Hematol. 2016 May;91(5):E296-7. doi: 10.1002/ajh.24334. Epub 2016 Apr 6.
10
Between a rock and a hard place: weighing thrombotic risk against bleeding complications.
Am J Cardiol. 2013 May 1;111(9):1375. doi: 10.1016/j.amjcard.2013.02.016.
引用本文的文献
1
The main protease (M) from SARS-CoV-2 triggers plasma clotting in vitro by activating coagulation factors VII and FXII.
Commun Biol. 2025 Aug 1;8(1):1145. doi: 10.1038/s42003-025-08570-2.
2
Dual antithrombotic therapy dose-dependently alters hemostatic plug structure and function.
J Thromb Haemost. 2024 Apr;22(4):1016-1023. doi: 10.1016/j.jtha.2023.12.017. Epub 2023 Dec 23.
3
Towards the generation of gnotobiotic larvae as a tool to investigate the influence of the microbiome on the development of the amphibian immune system.
Philos Trans R Soc Lond B Biol Sci. 2023 Jul 31;378(1882):20220125. doi: 10.1098/rstb.2022.0125. Epub 2023 Jun 12.
4
Murine cadherin-6 mediates thrombosis in vivo in a platelet-independent manner.
Res Pract Thromb Haemost. 2020 Dec 4;5(1):125-131. doi: 10.1002/rth2.12458. eCollection 2021 Jan.
5
Characterization of a transgenic mouse model of chronic conditional platelet depletion.
Res Pract Thromb Haemost. 2019 Sep 12;3(4):704-712. doi: 10.1002/rth2.12255. eCollection 2019 Oct.
6
Interrelationships between structure and function during the hemostatic response to injury.
Proc Natl Acad Sci U S A. 2019 Feb 5;116(6):2243-2252. doi: 10.1073/pnas.1813642116. Epub 2019 Jan 23.
本文引用的文献
1
Glutamate Receptor Interacting Protein 1 Mediates Platelet Adhesion and Thrombus Formation.
PLoS One. 2016 Sep 15;11(9):e0160638. doi: 10.1371/journal.pone.0160638. eCollection 2016.
2
Targeting the anionic region of human protease-activated receptor 4 inhibits platelet aggregation and thrombosis without interfering with hemostasis.
J Thromb Haemost. 2014 Aug;12(8):1331-41. doi: 10.1111/jth.12619. Epub 2014 Jun 27.
Zotero 插件